Evidence map›Paper›PMID 39127858›Full record

ArticleNPJ precision oncology2024

Interferon signaling and ferroptosis in tumor immunology and therapy.

Wei Hu, Ziqian Zhao, Jianxin Du, Jie Jiang, Minghao Yang, Maojin Tian, Peiqing Zhao

Erratum issuedAbstract read
In one paragraph

Article in NPJ precision oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. METTL3-mediated N6-methyladenosine modification ofProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Article
  4. Tumor-Intrinsic and Microenvironmental Determinants of Impaired Antitumor Immunity in Chromophobe Renal Cell Carcinoma.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Wei Hu *Department of Breast Surgery, Zibo Central Hospital Affiliated to Binzhou Medical University, Zibo, PR China.
Ziqian Zhao *The Second Medical College, Xinjiang Medical University, Urumqii, PR China.
Jianxin Du *Center of Translational Medicine, Zibo Central Hospital Affiliated to Binzhou Medical University, Zibo, PR China.
Jie JiangDepartment of Clinical Laboratory, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, PR China.
Minghao YangDepartment of Clinical Laboratory, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, PR China.
Maojin TianCenter of Translational Medicine, Zibo Central Hospital Affiliated to Binzhou Medical University, Zibo, PR China. bzjzzpq@sdu.edu.cn.
Peiqing ZhaoCenter of Translational Medicine, Zibo Central Hospital Affiliated to Binzhou Medical University, Zibo, PR China. phytian@163.com.ORCID http://orcid.org/0009-0001-7857-0391

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study sought to elucidate the mechanisms underlying the impact of the interferon signaling pathway on Ferroptosis in tumor cells and its correlation with CD8 + T cell exhaustion. Using mouse models and single-cell sequencing, the researchers studied the interaction between CD8 + T cells and the interferon signaling pathway. Differential gene analysis revealed key genes involved in CD8 + T cell exhaustion, and their downstream factors were explored using bioinformatics tools. The expression levels of interferon-related genes associated with Ferroptosis were analyzed using data from the TCGA database, and their relevance to tumor tissue Ferroptosis and patients' prognosis was determined. In vitro experiments were conducted to measure the levels of IFN-γ, MDA, and LPO, as well as tumor cell viability and apoptosis. In vivo validation using a mouse tumor model confirmed the results obtained from the in vitro experiments, highlighting the potential of silencing HSPA6 or DNAJB1 in enhancing the efficacy of PD-1 therapy and inhibiting tumor growth and migration.

Identifiers

PMID39127858
PMCPMC11316745

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.